What else does weight-loss drug Ozempic do? 5 unexpected health benefits
Injectable weight-loss drugs such as Ozempic have exploded in popularity over the past few years, yet scientists are still exploring how they affect our bodies.
In 2024, around 5 per cent of Britons had used an injectable glucagon-like peptide-1 (GLP-1) receptor agonist, a medication known under brand names such as Wegovy, Ozempic and Mounjaro. The drugs work by mimicking the hormone GLP-1 to slow down digestion and lower appetite, which can lead to significant weight loss.
But alongside the well-documented weight-loss effects, emerging scientific research has indicated that the medication may have other potential benefits, from reducing addictive behaviours to lowering the risk of Alzheimer's disease.
Here's a breakdown of some of Ozempic's unexpected side effects:
Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One 2025 study, published in the journal JAMA Psychiatry, found that semaglutide (the active ingredient in Ozempic) reduced cravings in people with alcohol use disorder.
Semaglutide is a medication that mimics a natural hormone to help regulate blood sugar and reduce appetite. It's used to treat type 2 diabetes and support weight loss.
The findings followed a 2024 study, published in the scientific journal Addiction, revealing that people taking Ozempic (or a similar medication) appeared to have a 40 per cent lower rate of opioid overdose.
'By modulating dopamine release, these medications appear to reduce cravings for alcohol, nicotine, ultra-processed foods, and even compulsive behaviours,' Dr Tamsin Lewis, founder of the London-based personalised healthcare service, Wellgevity, told the Standard.
She said she had observed this anecdotally in patients and that animal studies backed it up. 'This may be one of the most powerful aspects of these medications for long-term behaviour change,' Dr Lewis added.
Research has indicated that taking GLP-1 drugs can also lower the risk of developing Alzheimer's disease and dementia.
According to a 2024 study, semaglutide was associated with a 40 per cent to 70 per cent lower risk of an Alzheimer's diagnosis over three years compared with other diabetes treatments.
'This may be linked to reduced insulin resistance, which is increasingly being recognised as a driver of brain ageing,' said Dr Lewis.
According to Dr Mohamed Najjar, medical director of Jorja Healthcare Group, which offers weight-management treatments and also adult ADHD diagnosis, taking Ozempic may be able to soften the traits of attention-deficit/hyperactivity disorder (ADHD).
'This connection is based on the drug's potential effects on brain function and neurotransmitter regulation, which could be beneficial in managing ADHD symptoms [such as impulsivity and difficulty with focus],' he told the Standard.
However, Dr Najjar emphasised that there is limited research in this area and 'more studies are needed to establish the direct result of GLP-1 medication and ADHD'.
Research has indicated that semaglutide may reduce the risk of cardiovascular disease, including heart attacks and strokes.
'It appears to reduce inflammation, lower blood pressure, and improve endothelial function — all of which support vascular health,' Dr Lewis told the Standard.
GLP-1 drugs such as Ozempic have been linked to a reduction in diagnoses of depression and anxiety. 'GLP-1s slow gastric emptying and reduce gut inflammation, but they also influence vagal signalling and brain function via the gut-brain axis,' said Dr Lewis.
'Some patients report greater calm, satiety and mental clarity on these medications — although side effects like nausea and constipation need careful management.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
New Alzheimer's blood tests make diagnosis easier — but they're not right for everyone
The number of Americans with Alzheimer's disease, the most common cause of dementia in the U.S., is projected to rise significantly in the coming decades. The devastating disease has no cure, but the past several years have brought promising developments in new drug therapies and blood tests that help doctors treat and diagnose the disease. Here's what to know about the blood tests that diagnose Alzheimer's, one of which got full FDA approval in May. How they work Several commercially available blood tests have become available the past few years, most recently from biotech company Fujirebio Diagnostics, which got full approval from the FDA last month. Each test measures slightly different things, but overall they look for abnormal levels of certain proteins — amyloid and tau — in the blood. The accumulation of amyloid and tau proteins in the brain, often called plaques, are hallmark signs of Alzheimer's. If someone has tau plaques in the brain, for instance, some of that will leak out of the brain into the blood, resulting in a blood test result showing higher than normal levels of tau. In patients with symptoms of cognitive impairment, the tests predict an Alzheimer's diagnosis with about 90% accuracy. Why they're important The blood tests are a notable development because they are less expensive and less invasive than other types of testing that doctors have long used to diagnose patients with Alzheimer's. One is a PET scan, which involves injecting a patient with a radioactive tracer that binds to amyloid or tau in the brain so the presence of the proteins can be seen in a scan. It can cost several thousand dollars, compared to several hundred dollars for a blood test. The other is a spinal tap, which is painful or uncomfortable for many people. This method measures different forms of amyloid and tau in the spinal fluid. 'Up until these blood tests came out, a physician was stuck doing a PET scan or spinal tap, so not great options,' said Dr. Frank Longo, a professor of neurology at Stanford Medicine. 'The big breakthrough is finding something to measure in the blood that's about 90% accurate of what's going on in the brain, about as accurate as spinal fluid or a PET scan.' Doctors use the blood test as part of a broader medical evaluation that also includes a patient history, neurological exam and other testing. The blood test can help rule out Alzheimer's as the cause of a patient's cognitive impairment and potentially avoid unnecessary further testing. If someone's blood test comes back normal, for example, they may not have to undergo the PET scan or spinal tap, and their doctor can look into other potential causes of the cognitive impairment. 'That's the biggest practical thing it's doing now,' Longo said. It's important to distinguish Alzheimer's from other types of dementia because there are Alzheimer's treatments that have come out the last few years that help slow the progression of Alzheimer's. But patients must be in relatively early stages of the disease, with mild impairment or mild dementia, to be eligible. Some of the therapies have significant side effects, so patients would not want to start them unless they knew it was Alzheimer's, and not something else, causing the dementia. They're not for everyone The tests are approved only for people who already have symptoms of cognitive impairment and are of a certain age — 55 and over or 60 and over, depending on the test. They are not approved for healthy adults with normal cognition who want to diagnose or rule out Alzheimer's, or who are simply curious if they are at risk for developing Alzheimer's. They must be ordered by a doctor. They're becoming more common, but may not be covered by insurance Some of the blood tests have been available for a year or two, Longo said, but they were under an earlier and more limited type of FDA approval, not the full approval that the agency granted last month to the Fujirebio test. So they are poised to become more common. 'A year ago, most of my colleagues and I were not ordering these,' Longo said. 'I'd say less than 5% or 10% of the time we were ordering these. Now people are starting to order them in symptomatic patients. It's not rare now. They're starting to be recognized more.' Some primary care doctors are starting to order the tests as well, said Dr. Armen Moughamian, medical director of Sutter Health's Ray Dolby Brain Center at CPMC in San Francisco. The center treats patients with memory disorders. 'It's definitely a minority, but I've been seeing it done,' he said. As with many new medical tests, insurers may not cover them yet, but that usually evolves over time. Full FDA approval may help make the case for the tests to be covered, Longo said. 'There is some uncertainty and lack of clarity about whether insurance and Medicare pay,' Moughamian said. 'That creates some hesitancy for providers to order it.' They may one day be used to screen and diagnose healthy people earlier In people with Alzheimer's, amyloid plaques begin to form in the brain as many as 20 years before they show symptoms. Right now, newer therapies for Alzheimer's — like lecanemab and donanemab, which slow the progression of the disease — are approved only for people with symptoms. Those symptoms are mild cognitive impairment or mild dementia, the early stages of symptomatic Alzheimer's. This means people who have not yet developed symptoms, but who have amyloid plaques in the brain, cannot get these treatments. So if a blood test could be used in pre-symptomatic people, it could mean better screening and earlier diagnosis to larger groups of people. 'What we want to push for is earlier diagnosis because new therapies are available when we catch people in earlier stages,' Moughamian said. Moughamian is leading two clinical trials that examine whether drugs that remove amyloid in the brain, donanemab and another drug remternetug, can work in people who have amyloid plaques but have not yet developed symptoms. They are using an Alzheimer's blood test to see whether patients are eligible for the trial.
Yahoo
an hour ago
- Yahoo
7 Relationship Habits That Secretly May Be Signs Of ADHD
Do you find it difficult to focus on a task when your partner is talking to you? Do you go to bed much later than your partner? Do you take comments from your partner personally, even when they don't mean to criticize you? While everyone in relationships may experience these scenarios, when they happen often or to an extreme, they can be signs of ADHD (attention-deficit/hyperactivity disorder). ADHD 'is not just a deficit of attention or someone being hyperactive … [it's] very much about self-management.' said Dr. Lidia Zylowska, associate professor at the University of Minnesota School of Medicine and author of 'The Mindfulness Prescription for Adult ADHD.' 'It's really a different way of experiencing … or reacting to the world.' ADHD affects a person's executive functions, which are skills in the brain that help plan, organize, prioritize, complete tasks and regulate emotions. 'All of these play into relationships and … dynamics between couples,' explained Sharon Saline, a clinical psychologist who specializes in ADHD. '[And] sometimes the partner who doesn't have ADHD assumes that the partner who does have ADHD is doing things on purpose that they're not [intentionally] doing.' It's important for both partners to understand each other so they can have compassion and build a strong relationship, Zylowska added. We talked to therapists about habits in relationships that could be signs of ADHD — and tips for both partners for working through their differences: You may have 'challenges with emotional regulation, [such as] losing your temper, being overwhelmed by anxiety [or] having big feelings that you struggle to rein in,' Saline said. This includes a 'low frustration tolerance,' explained Terry Matlen, psychotherapist, founder of ADDConsults and author of 'The Queen of Distraction.' For example, you may have a tantrum about something that seems trivial, like losing the TV remote. 'This can … cause … friction and anger in the [other] partner and embarrassment in the person with ADHD,' she said. It's important to recognize what your triggers are and how you respond to them, she advised. 'Instead of acting … out in ways that can hurt others, give yourself a timeout,' she said. 'Head to the bathroom or other quiet space, [and] talk it out to yourself: 'I'm really angry/upset/hurt because ….'' Deep breathing, taking a warm bath or journaling also can help you calm down. 'If it's too late and you've lost control, apologize to your partner and make a plan for how to manage this moving forward,' she said. A lot of people who have ADHD may experience rejection sensitive dysphoria, which is a 'hypersensitivity to rejection or negative feedback like criticism,' explained Billy Roberts, founder and clinical director of Focused Mind ADHD Counseling. 'You may be actually quite sensitive to how you are scanning and noticing what's happening in the relationship,' Zylowska said. The person with ADHD may perceive that someone is trying to hurt or reject them, even when that's not necessarily happening, Matlen added. The person who doesn't have ADHD may 'tiptoe around their partner' because they're afraid of hurting their feelings. The person with ADHD may shut down because they're anticipating rejection or overact when their partner really isn't trying to criticize, Roberts said. Just being aware of the fact that this can happen when you have ADHD and being able to talk about this with your partner can make a difference, he advised. You could say something like, 'I got the impression that you were mad at me when I said that I couldn't pick up the laundry. Can we talk through that?' Roberts explained. Also ask yourself, 'Am I inferring tone here … or did [my partner] explicitly criticize me?' While it can come from impulsivity, 'people with ADHD [may also] interrupt because they got really excited about something that they just heard,' said Marcy Caldwell, clinical psychologist and founder and director of The Center For ADHD. But the other partner may be thinking, 'You didn't care about what I had to say.' It can be helpful when the person with ADHD owns their behavior and says something like, 'I know I interrupt a lot, and I'm really sorry. … How does it feel to you?' she said. And explain the reason behind the behavior, whether you are wanting to add to what they're saying or don't want to forget something. There also are behavioral tips that work for some people to help them not interrupt, like sitting on their hands or writing a thought down instead of saying it verbally, she said. Matlen also recommends looking at the person's lips while they are talking to hold their attention. 'It engages more than one of our senses: visual and audio,' she said. 'Using a fidget can also work wonders to keep your mind sharp and attentive.' If the partner with ADHD is hyper-focused on something, they may have a difficult time being pulled away from that, Caldwell explained. 'Let's say the ADHD person is writing or working on something and the partner comes in to ask a quick question, that can lead to some irritability or … [the partner feeling completely ignored],' Caldwell said. 'It just is really hard for an ADHD brain to be taken off task.' She recommends that the person with ADHD use a visual cue when they need to focus, such as wearing headphones or closing the door. Explain to your partner that's a sign to please not interrupt you unless it's an emergency or something time-sensitive. Someone with ADHD may have a hard time feeling internally motivated to do a task or goal if it's not interesting or feels particularly overwhelming, Roberts explained. Their partner may perceive it as that they are intentionally not doing a task, but in reality, their brains are just processing it differently. 'A neurotypical brain tends to be motivated by important things and by priorities, [like] it's important to do the dishes at the end of the night,' Caldwell said, adding that someone with ADHD tends 'to be motivated by competition, novelty, interest and pressure.' For example, someone may wait until 'there are no clean dishes and then it feels important to clean.' Have a conversation with your partner about what they like to do and do well, and take that into account when you're both deciding how to divide up household tasks, Saline said. For instance, maybe one partner likes to cook while the other prefers to handle maintenance of the house. Using apps that gamify chores and setting reminder notifications also can help both partners stay on track, Caldwell added. Someone with ADHD often feels 'like evening is the time … to catch up on everything,' Zylowska said. 'When they do get in bed … they may have trouble unwinding and listen to music, scroll through their phone or watch TV.' This can cause issues if their partner goes to bed earlier and is a light sleeper or really cares about going to bed at the same time as their partner. 'The … partner may feel isolated and lonely, [and] sexual relations may become sporadic,' Matlen said. 'The noise of an active, awake partner [also] can create sleep issues for the [other person].' Matlen recommends setting time before bed to cuddle together, even if each partner goes to sleep at a different time. If the night owl is disturbing the sleep of the other person, some couples may decide on separate bedrooms and connect other times throughout the day. Or if it's important for them to be in bed at the same time, one person could use headphones or a reading light while the other sleeps, Zylowska said. 'Finding ways to accept each other's rhythms versus trying to force them out of it is the way to go,' Matlen said. 'The spontaneity, intensity and fun that [a person with ADHD] can bring to you as a couple can be incredibly refreshing,' Matlen said. For example, the person with ADHD may always be looking for creative date ideas or new hobbies to try with their partner, Caldwell said. Or maybe they suggest spontaneous ways to spice up their romance, like a foot massage or taking a bubble bath, Matlen added. '[Usually] we partner with people who bring something different than what we [do],' Caldwell said. And having an appreciation for this and how your strengths complement each other is an important foundation for a healthy relationship. 'Tossing' Could Be A Potential Sign Of ADHD. Do You Do It? 12 Things Not To Say To Someone Who Has ADHD We Have ADHD. These Are The Apps We Swear By.
Chicago Tribune
2 hours ago
- Chicago Tribune
Jim Taylor: What my wife's experience with Alzheimer's has taught me
After several unexplained memory slips, there came a day when my wife, Geri, didn't recognize her own face in the mirror. That's when we knew it was time for her to get checked out. It was 2012, and Alzheimer's was a feared diagnosis. At the time, billions of dollars of investments into research and development had failed to produce treatments that could prevent, slow or cure the disease. Getting a definitive diagnosis would be extremely difficult, but the alternative was living with years of the landscape for Alzheimer's diagnosis and treatment has taken a great leap forward. It is increasingly possible to manage the disease and live a fulfilling life. We have reached a historic moment with the FDA's approval of the first blood biomarker tests for Alzheimer's. This long-awaited breakthrough means physicians can now detect early signs of Alzheimer's — which accounts for 70% of all cases of dementia — using a simple blood test that can be done during a regular check-up with your PET scans remain important for confirming a diagnosis, they are only available at specialized centers, typically in urban medical centers, and they are expensive. Blood biomarker tests now offer an easy first step in the diagnostic journey. They provide fast answers for people experiencing memory problems and can even spot early signs of cognitive decline years before symptoms appear. Without these tests, most people have a long, challenging path to wife Geri's path to diagnosis was anything but simple. In 2012, a neurologist confirmed she had mild cognitive impairment, a common precursor to Alzheimer's. It was a life-altering event. Over the next few years, we knew we had to dig deeper into the cause of her condition, to uncover any potential medical options. Eventually we found a clinical trial for an experimental Alzheimer's drug, and she received a PET scan to determine whether she qualified for the trial. Her brain scan detected amyloid plaque, the telltale sign of Alzheimer's. The diagnosis was difficult to face, but it meant we didn't have to struggle with uncertainty. We could act.I understand the fear that surrounds an Alzheimer's diagnosis, but catching it early helps. Changes in the brain begin years before memory problems become noticeable. The earlier the diagnosis, the more options people have. Research shows that anti-amyloid therapies are more effective when administered earlier: In one clinical trial, patients with early Alzheimer's showed 35% slowing of cognitive decline, compared with those on the placebo. These treatments can help people maintain their independence longer and make the most of their lucid was fortunate to participate in a clinical trial that significantly slowed her disease progression. The seven-year trial period was a game-changer for us. The regular infusions were a source of hope as we saw her benefit from the medication. This precious time allowed Geri to develop coping strategies to manage her disease. Together, we traveled across the country giving talks about living with Alzheimer's disease, and Geri needed very little assistance. We cherished this time together — years made possible because we sought answers early. Following the FDA's landmark approval of blood biomarker tests, the next step is making these tests widely available. Hospitals and health care systems across the country should ensure primary care physicians are aware of these tests and understand how to use them. Public education campaigns can raise awareness with people who have concerns about cognitive impairment and their detection gives people meaningful choices, and most importantly it gives people time. Time to benefit from lifestyle changes, participate in groundbreaking clinical trials, and access treatments when they can make the greatest difference. Although facing a potential Alzheimer's diagnosis is daunting, waiting only limits a person's options. If you're concerned that you or a loved one might have signs of cognitive impairment, please don't stay in the dark. Blood biomarker tests offer real hope in a new era of Alzheimer's care. The sooner we embrace these advances, the more precious time we can preserve.
